VSTM

#2683
Verastem, Inc.
5.72
+1.42%
Secteur:
Base:
Devise de Profit:
Range quotidien
5.72
5.72
Range Annuel
4.01
11.25
Changement quotidien
+1.42%
Changement Mensuel
-11.86%
Evolution sur 6 mois
-38.49%
Changement Annuel
+6.32%
Clôture Précédente
5.64
Open
5.72
Bid
Ask
Low
5.72
High
5.72
Volume
58
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 369.29 M
  • Employee 78
  • Founded 2010
  • CEO Brian Stuglik
  • Website www.verastem.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001J2LSK5
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.41
Price to sales ratio
18.46
Dividends per share
—
Dividend yield %
—

Verastem Inc

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

Nouvelles